210 related articles for article (PubMed ID: 11533142)
1. Impact of the renin-angiotensin system on cerebral perfusion following subarachnoid haemorrhage in the rat.
Fassot C; Lambert G; Elghozi JL; Lambert E
J Physiol; 2001 Sep; 535(Pt 2):533-40. PubMed ID: 11533142
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade.
Leenen FH; Yuan B
Hypertension; 2001 Mar; 37(3):981-4. PubMed ID: 11244027
[TBL] [Abstract][Full Text] [Related]
3. The peripheral renin-angiotensin system is not involved in the hypertension of sheep exposed to prenatal dexamethasone.
Peers A; Campbell DJ; Wintour EM; Dodic M
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):306-11. PubMed ID: 11251645
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the acute effects of angiotensin II by the receptor antagonist irbesartan in normotensive men.
Ribstein J; Picard A; Armagnac C; Sissmann J; Mimran A
J Cardiovasc Pharmacol; 2001 Apr; 37(4):449-60. PubMed ID: 11300658
[TBL] [Abstract][Full Text] [Related]
5. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of renin-angiotensin system for maintaining blood pressure control following subarachnoid haemorrhage.
Fassot C; Lambert G; Gaudet-Lambert E; Friberg P; Elghozi JL
Brain Res Bull; 1999 Sep; 50(2):127-32. PubMed ID: 10535331
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
[TBL] [Abstract][Full Text] [Related]
8. Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy?
Dendorfer A; Dominiak P; Tempel K; Raasch W
J Hypertens; 2005 Oct; 23(10):1861-7. PubMed ID: 16148610
[TBL] [Abstract][Full Text] [Related]
9. Obese female SHHF/Mcc-fa(cp) rats resist antihypertensive effects of renin-angiotensin system inhibition.
Sharkey LC; Holycross BJ; McCune SA; Radin MJ
Clin Exp Hypertens; 2001 Apr; 23(3):227-39. PubMed ID: 11339689
[TBL] [Abstract][Full Text] [Related]
10. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
Ruilope L
J Hypertens Suppl; 1997 Dec; 15(7):S15-20. PubMed ID: 9532516
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin-induced presynaptic facilitation of sympathetic neurotransmission in the pithed rat.
Streefkerk JO; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2002 Jun; 20(6):1175-80. PubMed ID: 12023688
[TBL] [Abstract][Full Text] [Related]
12. [Activation of the renin-angiotensin system and blood pressure variability in rats].
Blanc J; Lambert G; Elghozi JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960
[TBL] [Abstract][Full Text] [Related]
15. Effects of extract of ginkgo biloba on intracranial pressure, cerebral perfusion pressure, and cerebral blood flow in a rat model of subarachnoid haemorrhage.
Sun BL; Yuan H; Yang MF; Xia ZL; Zhang SM; Wang LX
Int J Neurosci; 2007 May; 117(5):655-65. PubMed ID: 17464783
[TBL] [Abstract][Full Text] [Related]
16. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
[TBL] [Abstract][Full Text] [Related]
17. Cushing's mechanism maintains cerebral perfusion pressure in experimental subarachnoid haemorrhage.
Barry CM; van den Heuvel C; Helps S; Vink R
Neurosci Lett; 2012 Oct; 529(1):92-6. PubMed ID: 22982148
[TBL] [Abstract][Full Text] [Related]
18. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
Kamide K; Rakugi H; Higaki J; Okamura A; Nagai M; Moriguchi K; Ohishi M; Satoh N; Tuck ML; Ogihara T
Am J Hypertens; 2002 Jan; 15(1 Pt 1):66-71. PubMed ID: 11824863
[TBL] [Abstract][Full Text] [Related]
19. A pharmacodynamic study of SR 47436, a selective AT1 receptor antagonist, on blood pressure in conscious cynomolgus monkeys.
Roccon A; Marchionni D; Donat F; Segondy D; Cazaubon C; Nisato D
Br J Pharmacol; 1994 Jan; 111(1):145-50. PubMed ID: 8012690
[TBL] [Abstract][Full Text] [Related]
20. No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.
Nap A; Balt JC; Pfaffendorf M; Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):100-5. PubMed ID: 12806592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
